Regional delivery of vancomycin using pluronic F-127 to inhibit methicillin resistant Staphylococcus aureus (MRSA) growth in chronic otitis media in vitro and in vivo
- 1 April 2004
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 96 (1), 1-7
- https://doi.org/10.1016/j.jconrel.2003.12.029
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Controlled release of vancomycin from Poloxamer 407 gelsInternational Journal of Pharmaceutics, 1999
- Comparative analysis of tetracycline-containing dental gels: Poloxamer- and monoglyceride-based formulationsInternational Journal of Pharmaceutics, 1996
- Percutaneous Absorption of Indomethacin from Pluronic F127 Gels in RatsJournal of Pharmacy and Pharmacology, 1995
- Biological Activity of Urease Formulated in Poloxamer 407 after Intraperitoneal Injection in the RatJournal of Pharmaceutical Sciences, 1992
- Sustained Delivery of Interleukin-2 from a Poloxamer 407 Gel Matrix Following Intraperitoneal Injection in MicePharmaceutical Research, 1992
- Anti-inflammatory Activity of Ketoprofen Gel on Carrageenan-Induced Paw Edema in RatsJournal of Pharmaceutical Sciences, 1990
- Acetobacter cellulose pellicle as a temporary skin substituteApplied Biochemistry and Biotechnology, 1990
- Pluronic F‐127 gel preparation as an artificial skin in the treatment of third‐degree burns in pigsJournal of Biomedical Materials Research, 1987
- Pluronic F-127 gels as a vehicle for topical administration of anticancer agents.CHEMICAL & PHARMACEUTICAL BULLETIN, 1984
- Artificial skin I. Preparation and properties of pluronic F‐127 gels for treatment of burnsJournal of Biomedical Materials Research, 1972